These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
240 related articles for article (PubMed ID: 26736813)
21. Correlation of Tumor Treating Fields Dosimetry to Survival Outcomes in Newly Diagnosed Glioblastoma: A Large-Scale Numerical Simulation-Based Analysis of Data from the Phase 3 EF-14 Randomized Trial. Ballo MT; Urman N; Lavy-Shahaf G; Grewal J; Bomzon Z; Toms S Int J Radiat Oncol Biol Phys; 2019 Aug; 104(5):1106-1113. PubMed ID: 31026557 [TBL] [Abstract][Full Text] [Related]
22. Modelling Tumor Treating Fields for the treatment of lung-based tumors. Bomzon Z; Urman N; Wenger C; Giladi M; Weinberg U; Wasserman Y; Kirson ED; Miranda PC; Palti Y Annu Int Conf IEEE Eng Med Biol Soc; 2015; 2015():6888-91. PubMed ID: 26737876 [TBL] [Abstract][Full Text] [Related]
23. Temperature and Impedance Variations During Tumor Treating Fields (TTFields) Treatment. Gentilal N; Abend E; Naveh A; Marciano T; Balin I; Telepinsky Y; Miranda PC Front Hum Neurosci; 2022; 16():931818. PubMed ID: 35898934 [TBL] [Abstract][Full Text] [Related]
24. NovoTTF™-100A System (Tumor Treating Fields) transducer array layout planning for glioblastoma: a NovoTAL™ system user study. Chaudhry A; Benson L; Varshaver M; Farber O; Weinberg U; Kirson E; Palti Y World J Surg Oncol; 2015 Nov; 13():316. PubMed ID: 26558989 [TBL] [Abstract][Full Text] [Related]
25. Enhancing Predicted Efficacy of Tumor Treating Fields Therapy of Glioblastoma Using Targeted Surgical Craniectomy: A Computer Modeling Study. Korshoej AR; Saturnino GB; Rasmussen LK; von Oettingen G; Sørensen JC; Thielscher A PLoS One; 2016; 11(10):e0164051. PubMed ID: 27695068 [TBL] [Abstract][Full Text] [Related]
26. Tumor treating fields (TTFields) delay DNA damage repair following radiation treatment of glioma cells. Giladi M; Munster M; Schneiderman RS; Voloshin T; Porat Y; Blat R; Zielinska-Chomej K; Hååg P; Bomzon Z; Kirson ED; Weinberg U; Viktorsson K; Lewensohn R; Palti Y Radiat Oncol; 2017 Dec; 12(1):206. PubMed ID: 29284495 [TBL] [Abstract][Full Text] [Related]
27. Guidelines for Burr Hole Surgery in Combination With Tumor Treating Fields for Glioblastoma: A Computational Study on Dose Optimization and Array Layout Planning. Cao F; Mikic N; Wong ET; Thielscher A; Korshoej AR Front Hum Neurosci; 2022; 16():909652. PubMed ID: 35782043 [TBL] [Abstract][Full Text] [Related]
28. Predicting the electric field distribution in the brain for the treatment of glioblastoma. Miranda PC; Mekonnen A; Salvador R; Basser PJ Phys Med Biol; 2014 Aug; 59(15):4137-47. PubMed ID: 25003941 [TBL] [Abstract][Full Text] [Related]
29. [Simulation model of tumor-treating fields]. Qin L; Xie X; Wang M; Ma M; Pan Y; Chen G; Zhang S Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2024 Apr; 41(2):360-367. PubMed ID: 38686418 [TBL] [Abstract][Full Text] [Related]
30. Enhancing Electric Field Distribution in the Pancreas for Improved TTFields Therapy: A Computational Modeling Investigation. Zheng M; Wang Y; Chen S; Suo Y; Yu J; Zhang X IEEE Trans Biomed Eng; 2024 Sep; 71(9):2612-2619. PubMed ID: 38564342 [TBL] [Abstract][Full Text] [Related]
31. Analysis of physical characteristics of Tumor Treating Fields for human glioblastoma. Lok E; San P; Hua V; Phung M; Wong ET Cancer Med; 2017 Jun; 6(6):1286-1300. PubMed ID: 28544575 [TBL] [Abstract][Full Text] [Related]
32. Global post-marketing safety surveillance of Tumor Treating Fields (TTFields) in patients with high-grade glioma in clinical practice. Shi W; Blumenthal DT; Oberheim Bush NA; Kebir S; Lukas RV; Muragaki Y; Zhu JJ; Glas M J Neurooncol; 2020 Jul; 148(3):489-500. PubMed ID: 32535723 [TBL] [Abstract][Full Text] [Related]
33. Integration of Tumor-Treating Fields into the Multidisciplinary Management of Patients with Solid Malignancies. Wang Y; Pandey M; Ballo MT Oncologist; 2019 Dec; 24(12):e1426-e1436. PubMed ID: 31444292 [TBL] [Abstract][Full Text] [Related]
34. First steps to creating a platform for high throughput simulation of TTFields. Hershkovich HS; Bomzon Z; Wenger C; Urman N; Chaudhry A; Garcia-Carracedo D; Kirson ED; Weinberg U; Wassermann Y; Palti Y Annu Int Conf IEEE Eng Med Biol Soc; 2016 Aug; 2016():2357-2360. PubMed ID: 28268799 [TBL] [Abstract][Full Text] [Related]
35. Prevention and Management of Dermatologic Adverse Events Associated With Tumor Treating Fields in Patients With Glioblastoma. Lacouture ME; Anadkat MJ; Ballo MT; Iwamoto F; Jeyapalan SA; La Rocca RV; Schwartz M; Serventi JN; Glas M Front Oncol; 2020; 10():1045. PubMed ID: 32850308 [No Abstract] [Full Text] [Related]
36. Tumor Treating Fields (TTFields) Hinder Cancer Cell Motility through Regulation of Microtubule and Acting Dynamics. Voloshin T; Schneiderman RS; Volodin A; Shamir RR; Kaynan N; Zeevi E; Koren L; Klein-Goldberg A; Paz R; Giladi M; Bomzon Z; Weinberg U; Palti Y Cancers (Basel); 2020 Oct; 12(10):. PubMed ID: 33080774 [TBL] [Abstract][Full Text] [Related]
37. Alternating electric fields (TTFields) in combination with paclitaxel are therapeutically effective against ovarian cancer cells in vitro and in vivo. Voloshin T; Munster M; Blatt R; Shteingauz A; Roberts PC; Schmelz EM; Giladi M; Schneiderman RS; Zeevi E; Porat Y; Bomzon Z; Urman N; Itzhaki A; Cahal S; Kirson ED; Weinberg U; Palti Y Int J Cancer; 2016 Dec; 139(12):2850-2858. PubMed ID: 27561100 [TBL] [Abstract][Full Text] [Related]
38. The Clinical Application of Tumor Treating Fields Therapy in Glioblastoma. Riley MM; San P; Lok E; Swanson KD; Wong ET J Vis Exp; 2019 Apr; (146):. PubMed ID: 31058901 [TBL] [Abstract][Full Text] [Related]
39. Assessment of electric field distribution in anisotropic cortical and subcortical regions under the influence of tDCS. Shahid S; Wen P; Ahfock T Bioelectromagnetics; 2014 Jan; 35(1):41-57. PubMed ID: 24122951 [TBL] [Abstract][Full Text] [Related]